• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有或不伴有男性乳房发育的睾丸肿瘤患者的内分泌学研究:45例报告

Endocrine studies in testicular tumor patients with and without gynecomastia: a report of 45 cases.

作者信息

Stepanas A V, Samaan N A, Schultz P N, Holoye P Y

出版信息

Cancer. 1978 Jan;41(1):369-76. doi: 10.1002/1097-0142(197801)41:1<369::aid-cncr2820410150>3.0.co;2-y.

DOI:10.1002/1097-0142(197801)41:1<369::aid-cncr2820410150>3.0.co;2-y
PMID:564234
Abstract

Prolactin (PRL), human placental lactogen (hPL), the beta-subunit of human chorionic gonadotropin (betahCG), testosterone (T), estrone (E1), and estradiol (E2) were measured in blood samples from 45 patients with testicular tumors, 27 of whom had gynecomastia at some stage of their disease. Forty-two of the 45 patients had at least one abnormal hormone level. The most common abnormality was that of plasma estrone: it was elevated in 32 out of 42 (76%) patients in whom it was measured, suggesting a useful role for E1 as a testicular tumor marker. Prognosis was notably worse in patients with embryonal carcinoma, teratocarcinoma, and choriocarcinoma, in those with gynecomastia and, particularly, galactorrhea. Such patients also had the highest incidence of hormonal abnormalities as well as the most extreme absolute values. Hormonal mechanisms were implicated in the development of gynecomastia and galactorrhea. Prolactin, betahCG, E1, and E2 levels in all permutations correlated significantly among patients with gynecomastia, but not among those without, while estrogen to testosterone ratios were elevated in patients with galactorrhea.

摘要

在45例睾丸肿瘤患者的血样中检测了催乳素(PRL)、人胎盘催乳素(hPL)、人绒毛膜促性腺激素β亚基(βhCG)、睾酮(T)、雌酮(E1)和雌二醇(E2)。其中27例在疾病的某个阶段出现了男性乳房发育。45例患者中有42例至少有一项激素水平异常。最常见的异常是血浆雌酮:在检测的42例患者中有32例(76%)升高,提示E1作为睾丸肿瘤标志物有一定作用。胚胎癌、畸胎癌和绒毛膜癌患者、有男性乳房发育尤其是伴有溢乳的患者预后明显较差。这类患者激素异常的发生率也最高,且绝对值最为极端。激素机制与男性乳房发育和溢乳的发生有关。在有男性乳房发育的患者中,PRL、βhCG、E1和E2的所有组合水平之间均显著相关,而在无男性乳房发育的患者中则不然,而有溢乳的患者中雌激素与睾酮的比值升高。

相似文献

1
Endocrine studies in testicular tumor patients with and without gynecomastia: a report of 45 cases.伴有或不伴有男性乳房发育的睾丸肿瘤患者的内分泌学研究:45例报告
Cancer. 1978 Jan;41(1):369-76. doi: 10.1002/1097-0142(197801)41:1<369::aid-cncr2820410150>3.0.co;2-y.
2
Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.评估五种肿瘤标志物(甲胎蛋白、癌胚抗原、人绒毛膜促性腺激素、人胎盘催乳素和妊娠相关血浆蛋白A)在监测睾丸生殖细胞肿瘤患者的治疗及随访中的作用。
Oncology. 1983;40(1):1-10. doi: 10.1159/000225681.
3
Hormonal changes in urine and plasma by hormone-producing testicular tumors before and after treatment.激素分泌性睾丸肿瘤治疗前后尿液和血浆中的激素变化。
Acta Endocrinol Suppl (Copenh). 1971;152:26.
4
Applications of biologic tumor markers in testicular cancer.生物肿瘤标志物在睾丸癌中的应用。
Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1643-7.
5
Serum placental lactogen activity in patients with molar pregnancy and trophoblastic tumors--a reliable index of malignancy.
Am J Obstet Gynecol. 1971 Jun 15;110(4):583-7. doi: 10.1016/0002-9378(71)90703-4.
6
Hormonal profile of Leydig cell tumors with gynecomastia.伴有男性乳腺增生的睾丸间质细胞瘤的激素谱
J Clin Endocrinol Metab. 1984 Oct;59(4):625-30. doi: 10.1210/jcem-59-4-625.
7
[Testosterone and estradiol levels in male gynecomastia. Clinical and endocrine findings during treatment with tamoxifen].[男性乳腺增生症中的睾酮和雌二醇水平。他莫昔芬治疗期间的临床和内分泌学发现]
Dtsch Med Wochenschr. 1984 Nov 2;109(44):1678-82. doi: 10.1055/s-2008-1069434.
8
Hormone profiles and contralateral testicular histology in Down's syndrome with unilateral testicular tumor.唐氏综合征合并单侧睾丸肿瘤患者的激素谱及对侧睾丸组织学
Arch Androl. 1993 Mar-Apr;30(2):93-8. doi: 10.3109/01485019308987740.
9
The significance of measurement of human placental lactogen, human chorionic gonadotropin, and carcinoembryonic antigen in patients with ovarian carcinoma.人胎盘生乳素、人绒毛膜促性腺激素及癌胚抗原检测在卵巢癌患者中的意义
Am J Obstet Gynecol. 1976 Sep 15;126(2):186-9. doi: 10.1016/0002-9378(76)90273-8.
10
Endocrinological studies in patients with metastatic malignant testicular germ cell tumours.
Int J Androl. 1980 Oct;3(5):487-501. doi: 10.1111/j.1365-2605.1980.tb00137.x.

引用本文的文献

1
Multiparametric Ultrasound for Diagnosing Testicular Lesions: Everything You Need to Know in Daily Clinical Practice.用于诊断睾丸病变的多参数超声:日常临床实践中你需要了解的一切。
Cancers (Basel). 2023 Nov 8;15(22):5332. doi: 10.3390/cancers15225332.
2
Is gynecomastia related to the disease characteristics and prognosis in testicular germ cell tumor patients?男性乳房发育症与睾丸生殖细胞肿瘤患者的疾病特征和预后有关吗?
Diagn Interv Radiol. 2019 May;25(3):189-194. doi: 10.5152/dir.2019.18297.
3
CT measurement of breast glandular tissue and its association with testicular cancer.
乳腺腺体组织的CT测量及其与睾丸癌的关联。
Eur Radiol. 2017 Feb;27(2):536-542. doi: 10.1007/s00330-016-4414-3. Epub 2016 May 26.
4
Paraneoplastic syndromes.副肿瘤综合征
West J Med. 1980 Mar;132(3):189-208.
5
The gonadotropin response to synthetic gonadotropin releasing factor in patients with testicular cancer.睾丸癌患者对合成促性腺激素释放因子的促性腺激素反应。
Urol Res. 1983;11(2):69-73. doi: 10.1007/BF00256950.
6
Advances in pathology and immunocytochemistry.病理学与免疫细胞化学的进展
J R Soc Med. 1985;78 Suppl 6(Suppl 6):9-18.
7
Serum estradiol as a tumour marker for non-seminomatous germinal cell tumours (NSGCT) of the testis.血清雌二醇作为睾丸非精原性生殖细胞肿瘤(NSGCT)的肿瘤标志物。
Int Urol Nephrol. 1987;19(4):415-8. doi: 10.1007/BF02550358.